Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 06/10/20211 min de lecture
Issuance of Priority Review Voucher; Rare Pediatric Disease Product; Withdrawal
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is withdrawing the notice that published in the Federal Register of September 30, 2021, that announced the issuance of a priority review voucher to the sponsor of a rare pediatric disease product application. The Federal Register notice was published in error and is being withdrawn.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →